Advertisement
U.S. markets closed
S&P Futures
6,011.25 +24.25 (+0.41%) Dow Futures
44,616.00 +221.00 (+0.50%) Nasdaq Futures
20,950.50 +100.75 (+0.48%) Russell 2000 Futures
2,438.70 +25.10 (+1.04%) Crude Oil
71.28 +0.04 (+0.06%) Gold
2,718.40 +6.20 (+0.23%)
VKTX Nov 2024 72.000 call
OPR - OPR Delayed Price. Currency in USD
Follow
As of 02:50PM EST. Market open.
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 72.00 |
| Expire Date | 2024-11-22 |
| Day's Range | 0.0500 - 0.0500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 72 |
Motley Fool3 Monster Stocks in the Making
Here's why they think biotech stocks CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) could become much larger. David Jagielski (CRISPR Therapeutics): If you're looking for stocks with mammoth upside, you might be tempted to look for risky stocks that don't have any approved drugs or treatments yet. In December 2023, regulators approved Casgevy, which is a gene-editing therapy the company has been developing with Vertex Pharmaceuticals.
Investor's Business DailyRFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.